IDH1 and cancer: Regarding lipid metabolism, Stuani and colleagues studied acute myeloid leukemia cells with a mutation in the enzyme isocitrate dehydrogenase (IDH1), which is common in these resistant cancer cells, and demonstrated the association of the mutation with the impaired lipid anabolism in these cells [64].